VREOF (Vireo Growth) Cyclically Adjusted Revenue per Share: $17.48 (As of Mar. 2026)


VREOF Vireo Growth Inc VREOF
46 GF Score
Price $10.10
GF Value $9.69
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Cyclically Adjusted Revenue per Share?

Vireo Growth VREOF +1.20% 46 Cyclically Adjusted Revenue per Share is $17.48 as of Mar. 2026. GuruFocus rates VREOF with a GF Score™ of 46/100 and a GF Value™ of $9.69 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vireo Growth's adjusted revenue per share for the three months ended in Mar. 2026 was $2.949. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $17.48 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vireo Growth's average Cyclically Adjusted Revenue Growth Rate was -2.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vireo Growth was 3.50% per year. The lowest was -5.50% per year. And the median was 0.85% per year.

As of today (2026-07-08), Vireo Growth's current stock price is $10.10. Vireo Growth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $17.48. Vireo Growth's Cyclically Adjusted PS Ratio of today is 0.58.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vireo Growth was 12.35. The lowest was 0.17. And the median was 0.90.


Vireo Growth  (OTCPK:VREOF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vireo Growth's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.10/17.48
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vireo Growth was 12.35. The lowest was 0.17. And the median was 0.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vireo Growth Cyclically Adjusted Revenue per Share Related Terms


Vireo Growth Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Vireo Growth's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth Cyclically Adjusted Revenue per Share Chart

Vireo Growth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.32 18.04 19.29 17.75 18.22

Vireo Growth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.58 18.26 17.81 18.22 17.48

VREOF vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Cyclically Adjusted PS Ratio falls into.


VREOF
46GF Score
Vireo Growth Inc VREOF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vireo Growth Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vireo Growth's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.949/330.2130*330.2130
=2.949

Current CPI (Mar. 2026) = 330.2130.

Vireo Growth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 2.901 254.202 3.768
201906 8.697 256.143 11.212
201909 8.810 256.759 11.330
201912 1.188 256.974 1.527
202003 4.107 258.115 5.254
202006 3.706 257.797 4.747
202009 3.326 260.280 4.220
202012 3.581 260.474 4.540
202103 3.408 264.877 4.249
202106 3.400 271.696 4.132
202109 3.174 274.310 3.821
202112 3.222 278.802 3.816
202203 3.663 287.504 4.207
202206 4.939 296.311 5.504
202209 4.414 296.808 4.911
202212 4.458 296.797 4.960
202303 4.469 301.836 4.889
202306 4.729 305.109 5.118
202309 5.238 307.789 5.620
202312 5.063 306.746 5.450
202403 5.049 312.332 5.338
202406 5.246 314.175 5.514
202409 3.749 315.301 3.926
202412 3.221 315.605 3.370
202503 2.004 319.799 2.069
202506 2.579 322.561 2.640
202509 2.895 324.800 2.943
202512 2.969 324.054 3.025
202603 2.949 330.213 2.949

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $17.48 mean?
Vireo Growth (VREOF) has a Cyclically Adjusted Revenue per Share of $17.48 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vireo Growth and its competitors.
Is Vireo Growth's Cyclically Adjusted Revenue per Share too high?
Vireo Growth's current Cyclically Adjusted Revenue per Share is $17.48. Overall, Vireo Growth has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Vireo Growth's Cyclically Adjusted Revenue per Share of $17.48 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vireo Growth and its competitors. Vireo Growth's current Cyclically Adjusted Revenue per Share is $17.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOF) is currently considered Fairly Valued. The stock's GF Value™ is $9.69, compared to a current price of $10.10 — trading 4.2% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $17.48. Vireo Growth's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Vireo Growth (VREOF), the current Cyclically Adjusted Revenue per Share is $17.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (VREOF) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of $10.10 is trading 4.2% above its estimated GF Value™ of $9.69. GuruFocus considers Vireo Growth to be Fairly Valued.

Key valuation signals for VREOF:

  • Cyclically Adjusted Revenue per Share: $17.48
  • GF Value™: $9.69 vs. price of $10.10 (4.2% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the VREOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vireo Growth Business Description

Other Exchanges K95:GermanyVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
46GF Score

Get the complete analysis for VREOF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price
$9.69
GF Value